Baxter Q4 GAAP EPS loss ($2.01), adj. $0.44; sales $2.97B +8%; div cut to $0.01

BAXTER INTERNATIONAL INC

2025-FY EPS reported -$1.87 revenue$11,244,000,000

Q4 sales $2.97B (+8% reported, +3% operational); GAAP diluted EPS loss ($2.01), adjusted diluted EPS $0.44.
Board appoints Michael R. McDonnell (former Biogen CFO); directors Cathy Smith and Stephen Rusckowski resign effective Feb 13.
Quarterly dividend declared at $0.01 per share, payable April 1, 2026 to holders of record Feb 27, 2026.
CEO Hider: Q4 results missed expectations; new operating model aims to simplify organization and accelerate innovation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.